NEW YORK, Nov. 16, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD; NEO: MMED; DE: MMQ; the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased ...

A single dose of the psychedelic drug LSD may ease generalized anxiety disorder for months, a clinical trial has found. The trial results, published Thursday (Sept. 4) in JAMA, include data from 194 ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

A single dose of LSD can cut anxiety in half within weeks, according to the results of a new study conducted by a biopharmaceutical company. MindMed, a clinical-stage company that develops novel ...

Drug overdoses can be life threatening, but for two women who accidentally took massive hits of LSD the experience was life changing -- and in a good way. A 46-year-old woman snorted a staggering 550 ...

While dosing is the most significant determinant, other psychological and pharmacological factors also play a critical role. A positive mood before drug intake was strongly linked to elevated ratings ...

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

A new study published in the journal Neuropsychopharmacology provided results from one of the first modern clinical investigations of its kind to compare the effects of psychedelic drugs lysergic acid ...